Skip to main content
. 2021 Dec 23;14(1):60. doi: 10.3390/cancers14010060
CRS cytoreductive surgery
CRC colorectal cancer
DFS disease-free survival
HIPEC hyperthermic intraperitoneal chemotherapy
mOS median overall survival
MSI/MSS microsatellite instability/stability
PM peritoneal metastasis
PCI peritoneal cancer index
RCT randomized controlled trial